| COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1204 | 2020 |
| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 618 | 2020 |
| How to get started in quality improvement B Jones, E Vaux, A Olsson-Brown Bmj 364, 2019 | 138 | 2019 |
| SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy CE Higham, A Olsson-Brown, P Carroll, T Cooksley, J Larkin, P Lorigan, ... Endocrine connections 7 (7), G1-G7, 2018 | 135 | 2018 |
| Interferon-gamma–producing CD8+ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor–colitis SC Sasson, SM Slevin, VTF Cheung, I Nassiri, A Olsson-Brown, E Fryer, ... Gastroenterology 161 (4), 1229-1244. e9, 2021 | 98 | 2021 |
| The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 I Anil, R Arnold, S Benkwitz-Beford, S Branford, N Campton, JB Cazier, ... The Lancet Oncology 21 (5), 622-624, 2020 | 69 | 2020 |
| Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way? VTF Cheung, T Gupta, A Olsson-Brown, S Subramanian, SC Sasson, ... British Journal of Cancer 123 (2), 207-215, 2020 | 55 | 2020 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 49 | 2022 |
| Limiting moral injury in healthcare professionals during the COVID-19 pandemic M Roycroft, D Wilkes, S Pattani, S Fleming, A Olsson-Brown Occupational Medicine 70 (5), 312-314, 2020 | 40 | 2020 |
| Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions DJ Naisbitt, A Olsson‐Brown, A Gibson, X Meng, MO Ogese, A Tailor, ... Allergy 75 (4), 781-797, 2020 | 31 | 2020 |
| Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles W Ye, A Olsson-Brown, RA Watson, VTF Cheung, RD Morgan, I Nassiri, ... British Journal of Cancer 124 (10), 1661-1669, 2021 | 29 | 2021 |
| Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction A Olsson-Brown, R Lord, J Sacco, J Wagg, M Coles, M Pirmohamed Endocrine Connections 9 (4), 318-325, 2020 | 25 | 2020 |
| Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a … SC Sasson, JJ Zaunders, K Nahar, CML Munier, BP Fairfax, ... Clinical & Experimental Immunology 202 (3), 335-352, 2020 | 21 | 2020 |
| Checkpoint inhibition reduces the threshold for drug-specific T-cell priming and increases the incidence of sulfasalazine hypersensitivity S Hammond, A Olsson-Brown, S Grice, A Gibson, J Gardner, ... Toxicological Sciences 186 (1), 58-69, 2022 | 20 | 2022 |
| An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from … MR Middleton, F Aroldi, J Sacco, MM Milhem, BD Curti, AM Vanderwalde, ... Journal of clinical oncology 38 (15_suppl), e22050-e22050, 2020 | 20 | 2020 |
| UK Coronavirus Monitoring Project Team: COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study LY Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... Lancet 395 (10/241), 1919-1926, 2020 | 19 | 2020 |
| Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? OJ Pickles, LYW Lee, T Starkey, L Freeman-Mills, A Olsson-Brown, ... British journal of cancer 123 (5), 691-693, 2020 | 17 | 2020 |
| UK Coronavirus Cancer Monitoring Project Team COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a … LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... Lancet Oncol 21 (10), 1309-1316, 2020 | 15 | 2020 |
| Preventing psychological injury during the covid-19 pandemic M Roycroft, D Wilkes, S Fleming, S Pattani, A Olsson-Brown bmj 369, 2020 | 14 | 2020 |
| Using QR codes to enable quick access to information in acute cancer care J Upton, A Olsson-Brown, E Marshall, J Sacco British Journal of Nursing 26 (10), S4-S12, 2017 | 14 | 2017 |
